Cytek Biosciences, Inc. CTKB EMEA — Total revenue, net
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s emea — total revenue, net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s EMEA — total revenue, net?
- Cytek Biosciences, Inc. (CTKB) reported EMEA — total revenue, net of $10.77M in Q1 2026.
- How has Cytek Biosciences, Inc.'s EMEA — total revenue, net changed year-over-year?
- Cytek Biosciences, Inc.'s EMEA — total revenue, net decreased by 6.9% year-over-year, from $11.57M to $10.77M.
- What is the long-term trend for Cytek Biosciences, Inc.'s EMEA — total revenue, net?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s EMEA — total revenue, net has grown at a 10.9% compound annual growth rate (CAGR), from $36.97M to $55.88M.
- What does EMEA — total revenue, net mean?
- This metric represents the total net revenue generated from the sale of products and services within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and commercial success in these territories, serving as a key indicator of regional demand for cell analysis solutions. Investors use this to assess the geographic diversification of the company's revenue streams and the effectiveness of its international sales strategy.